Pasithea Therapeutics Corp.

KTTA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$14-$16-$12-$2
Dep. & Amort.$1$1$0$0
Deferred Tax$0$0$0-$2
Stock-Based Comp.$0$1$0$0
Change in WC-$2$2$1$0
Other Non-Cash$1-$1-$3$1
Operating Cash Flow-$14-$13-$14-$3
Investing Activities
PP&E Inv.$0-$0-$0-$0
Net Acquisitions$0$0-$2$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0-$1$0
Investing Cash Flow$0$0-$3-$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$5$0$0$50
Stock Repurch.$0-$4$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0-$3$6
Financing Cash Flow$5-$4-$3$56
Forex Effect-$0-$0-$0-$0
Net Chg. in Cash-$9-$17-$20$53
Supplemental Information
Beg. Cash$16$33$53$0
End Cash$7$16$33$53
Free Cash Flow-$14-$13-$14-$3